SAN FRANCISCO, May 24, 2017 /PRNewswire/ -- Kindred Biosciences,
Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving
and improving the lives of pets, today announced that
Denise Bevers, Co-Founder and COO,
will be presenting and hosting one-on-one investor meetings at the
7th Annual LD Micro Invitational in Los Angeles, CA on Tuesday, June 6, 2017 at 1:30 PM PST. The conference will be held at the
Luxe Sunset Bel Air Hotel.
Following the presentation, the slide deck will be available for
30 days on the Company's website:
http://kindredbio.com/investor-relations/events.
About Kindred Biosciences, Inc.
Kindred Biosciences is a development-stage biopharmaceutical
company focused on saving and improving the lives of pets.
Its mission is to bring to pets the same kinds of safe and
effective medicines that human family members enjoy. The
Company's strategy is to identify compounds and targets that have
already demonstrated safety and efficacy in humans and to develop
therapeutics based on these validated compounds and targets for
dogs, cats and horses. The Company has a deep pipeline of
novel drugs and biologics in development across many therapeutic
classes.
For more information or to download the corporate presentation,
visit www.KindredBio.com/LearnMore. Stay connected with KindredBio
on Facebook at www.Facebook.com/KindredBio.
Contact
Russell Radefeld
KindredBio
Russell.radefeld@kindredbio.com
(650) 701-7904
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/kindred-biosciences-to-present-at-7th-annual-ld-micro-invitational-300462801.html
SOURCE Kindred Biosciences, Inc.